Nasacort AQ Warnings
Buy Nasacort AQNasacort AQ Information
Nasacort AQ Warnings
Nasacort Oral Inhaler: Particular care is needed in patients who are transferred from systemically active corticosteroids to triamcinolone acetonide Oral Inhaler because deaths due to adrenal insufficiency have occurred in asthmatic patients during and after transfer from systemic corticosteroids to aerosolized steroids in recommended doses. After withdrawal from systemic corticosteroids, a number of months is usually required for recovery of hypothalamic-pituitary- adrenal (HPA) function. For some patients who have received large doses of oral steroids for long periods of time before therapy with triamcinolone acetonide Oral Inhaler is initiated, recovery may be delayed for one year or longer. During this period of HPA suppression, patients may exhibit signs and symptoms of adrenal insufficiency when exposed to trauma, surgery or infections, particularly gastroenteritis or other conditions with acute electrolyte loss. Although Nasacort Oral Inhaler may provide control of asthmatic symptoms during these episodes, in recommended doses it supplies only normal physiological amounts of corticosteroid systemically and does NOT provide the increased systemic steroid which is necessary for coping with these emergencies.°During periods of stress or a severe asthmatic attack, patients who have been recently withdrawn from systemic corticosteroids such as Nasacort, should be instructed to resume systemic steroids (in large doses) immediately and to contact their physician for further instruction. These patients should also be instructed to carry a warning card indicating that they may need supplementary systemic steroids during periods of stress or a severe asthma attack.
Buy Nasacort AQ